Alvotech Suffers Delay On Higher-Strength Adalimumab In US

Source : 'Generics Bulletin'

...

Celltrion’s COVID-19 Treatment Regdanvimab Is Approved In Korea

Source : 'Generics Bulletin'

...

The Medicines Patent Pool Plots A Post-Pandemic Future: Interview With Director Charles Gore

Source : IN VIVO

The COVID-19 pandemic has re-energized the debate on global access to essential medicines.  

Access to medicines is a big, complex question.  For the Medicines Patent Pool, IP is a critical...

EU’s Health Emergency Response Plans Must Address Existing Flaws

Source : 'Generics Bulletin'

Plans to create an EU Health Emergency Response Authority have been welcomed by European off-patent industry association Medicines for Europe. However, the group has emphasized that current policy and regulatory...

Biocon Biologics And Serum Institute Join Forces

Source : 'Generics Bulletin'

...